Hem

Patient management

Satellite symposium

Why use of long acting injectables is an urgent issue

Long acting injectable antipsychotics are often withheld until later stages of schizophrenia, but...

Seasonal problems will be magnified by Covid-19

For people with mental illness or disabling neurological conditions, restrictions imposed to...

Congress highlights

ICHD-3: What’s changed?

The new ICHD-3 guidelines include changes in the diagnostic criteria and terminology for several...

Parkinsons sjukdom

Satellite symposium

Timely intervention in advanced Parkinson’s disease

Managing Parkinson’s disease is as much about timing as anything else. Along with the...

Alzheimers sjukdom

Congress highlights

Guidance needed on biomarker counseling

Clinicians value biomarkers when assessing mild cognitive impairment but are less certain about how...

Alzheimers sjukdom

Congress highlights

Imaging advances diagnosis and staging in dementias

Tau-PET imaging in the clinic is on the horizon and would complement amyloid-PET and structural and...

Pandemic brings challenge and opportunity for people with schizophrenia

The COVID-19 pandemic risks exacerbating symptoms in people prone to experience reality in unusual...

Making sense of exercise in schizophrenia - No sweat!

Clinicians are well aware that cardiorespiratory fitness and cognition are related in schizophrenia...

Congress highlights

How are genes involved in tailoring psychiatric treatment?

Psychiatrists need an understanding of genome-wide association studies (GWAS), pharmacogenomics,...

Congress highlights

The new technologies transforming psychiatric practice and patient outcomes

Data-driven approaches to psychiatric diagnosis and practice fueled by the abundance of information...

Depression, Schizofreni

Congress highlights

Measurement-based care: How can we improve outcomes for patients with depression and schizophrenia

Measurement-based care (MBC) can improve outcomes and reduce health disparities for serious mental...

Congress highlights

Identifying and managing major depressive disorder with mixed features

One in five people with major depressive disorder (MDD) have at least three hypomanic symptoms, and...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Ireland Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine

Du lämnar Progress in Mind Sverige

Cancel

Du lämnar Progress in Mind Sverige

Progress in Mind Sverige
Registera för nyhetsbrev här

För att få tillgång, var god ange detaljer för att verifiera att du är sjukvårdspersonal.

Om du inte bor i Sverige klicka här

Logga in Registrera dig

Login as a registered health care professional

Vänligen ange din e-post för att fortsätta

Registrera dig som sjukvårdspersonal

Vänligen ange din e-post för att fortsätta

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

Den här informationen är endast avsedd för hälso- och sjukvårdspersonal

Acceptera

Neka